ImageneBio, Inc. (IMA) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$800.0K

Net Income/Loss (FY2025)

-$45.3M

Total Assets (FY2025)

$153.0M

Total Equity (FY2025)

$133.1M

Cash Flows from Operating Activities (FY2025)

-$47.8M

Source: ImageneBio, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.